Proteogenix

Proteogenix is a corporation based in Portland, Oregon, United States, that develops and markets biomarker diagnostic tests for the detection of life-threatening pregnancy-related conditions. Proteogenix is currently developing non-invasive protein biomarker screening tests for intra-amniotic infection, premature birth, and Down syndrome, which combined cause 175,000 premature births each year in the United States alone.

cite news
url=http://biospace.com/news_company.aspx?CompanyID=2045
publisher=Biospace.com
title=ProteoGenix News from The BioSpace Beat
date=September 29, 2004

]

References

External links

* [http://www.proteogenix.com/ Proteogenix Corporation Company Website]
* [http://news.bbc.co.uk/2/hi/health/3930551.stm BBC NEWS Article on an Intra-amniotic Infection study by Proteogenix]
* [http://medir.ohsu.edu/~geneview/images/nagalla.wmv Video of local news channel KOIN 6 News covering Intra-amniotic Infection research]